e-learning
resources
Vienna 2012
Sunday, 02.09.2012
New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of transcription factor PAX-5 (BSAP) in asthma severity and in the activity of allergic inflammation
V. Mineev, L. Sorokina, M. Nyoma, G. Lipkin, V. Lim, A. Eremeeva, Y. Malfygina, V. Ivanov, V. Trofimov (Saint-Petersburg, Russian Federation)
Source:
Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Session:
New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Session type:
Thematic Poster Session
Number:
779
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Mineev, L. Sorokina, M. Nyoma, G. Lipkin, V. Lim, A. Eremeeva, Y. Malfygina, V. Ivanov, V. Trofimov (Saint-Petersburg, Russian Federation). The role of transcription factor PAX-5 (BSAP) in asthma severity and in the activity of allergic inflammation. Eur Respir J 2012; 40: Suppl. 56, 779
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Protective effect of transcription factor PAX-5 (BSAP) on asthma severity
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Transcription factor GATA-3 as a specific marker of allergic bronchial asthma
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
New aspects of the action of IL-4 on the activity of the transcription factor STAT6 in allergic and non-allergic asthma
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
GATA-3 or T-bet: Who is the crucial marker of allergic bronchial asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Increased expression of lymphocyte transcription factor T-bet in COPD
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Asthma and diabetes: Possible markers of their co-existence. The possible role of transcription factors GATA-3 and T-bet and negative regulator of transcription SOCS1 in the worsening of asthma
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Allergic inflammatory cells use different GATA factors to activate CCR3 transcription
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012
TNFAIP3/A20 expression in allergic asthma
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies
Source: Eur Respir J 2001; 18: 466-473
Year: 2001
The asthma-like phenotype in VIP
-/-
mice may be related to activation of transcription factor NFAT
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008
A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Transcriptional factors F???3, ?-Maf, GATA3 and T-bet in different variants of bronchial asthma
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
Overexpression of suppressor of cytokine signaling-5 augments eosinophilic inflammation in an asthma model
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004
Gene polymorphism of epidermal growth factor receptor (EGFR) and airway hyperresponsiveness (AHR) in young allergic subjects without respiratory symptoms
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
The basic helix-loop-helix transcription factor scleraxis (Scx) is overexpressed in systemic and lung fibrosing diseases
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Reduced expression of the transcription factor KLF4 in COPD macrophages is associated with dysfunctional differentiation
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept